Capstone Investment Advisors, LLC Insulet Corp Put Options Transaction History

Capstone Investment Advisors, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$180.69 - $239.01 $162,621 - $215,109	900 Added 39.13%	3,200 $744,000
Q2 2024 Aug 14, 2024	SELL	$161.02 - $206.98 $48,306 - $62,094	-300 Reduced 11.54%	2,300 $464,000
Q1 2024 May 01, 2024	BUY	$163.6 - $209.11 $65,440 - $83,644	400 Added 18.18%	2,600 $445,000
Q4 2023 Feb 12, 2024	BUY	$127.77 - $221.42 $127,770 - $221,420	1,000 Added 83.33%	2,200 $477,000
Q3 2023 Nov 13, 2023	BUY	$154.67 - $290.89 $185,603 - $349,068	1,200 New	1,200 $191,000
Q4 2019 Feb 14, 2020	SELL	$144.81 - $186.0 $506,835 - $651,000	-3,500 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$117.35 - $167.95 $410,725 - $587,825	3,500 New	3,500 $577,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.3B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.